As shown in Fig 5, the pooled HR for OS in CMML patients was 2.223 (95% CI: 1.493–3.308, P <0.001), suggesting that SETBP1 mutation may also be a factor of the poor prognosis in CMML patients. This evidence concerns the gene SETBP1 and chronic myelomonocytic leukemia.